There are four coronavirus vaccines in late-stage studies; here’s how they differ
September 25, 2020 at 14:44 PM EDT
Johnson & Johnson’s investigational COVID-19 vaccine entered Phase 3 clinical trials this week, making it the fourth vaccine candidate in the U.S. to do so and providing additional details that can help investors differentiate the pool of late-stage coronavirus vaccines.
